Clinical trial
Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular…
NCT00247494 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other · Unknown status
Key facts
| NCT number | NCT00247494 |
|---|---|
| Title | Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients |
| Official title | Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients |
| Lead sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection, Atherosclerosis |
| Intervention type | Drug |
| Interventions | mycophenol mofetil (MMF, Cellcept®) 500 mg BID |
| Enrollment | 90 |
| Start date | Apr 1, 2005 |
| First posted | Nov 2, 2005 |
| Last update posted | Jul 22, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: